|
1
|
Barry S: Non-steroidal anti-inflammatory
drugs inhibit bone healing: A review. Vet Comp Orthop Traumatol.
23:385–392. 2010.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Cottrell J and O'Connor JP: Effect of
non-steroidal anti-inflammatory drugs on bone healing.
Pharmaceuticals (Basel). 3:1668–1693. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Pountos I, Georgouli T, Blokhuis TJ, Pape
HC and Giannoudis PV: Pharmacological agents and impairment of
fracture healing: What is the evidence? Injury. 39:384–394.
2008.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Patschan D, Loddenkemper K and Buttgereit
F: Molecular mechanisms of glucocorticoid-induced osteoporosis.
Bone. 29:498–505. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Canalis E: Mechanisms of glucocorticoid
action in bone. Curr Osteoporos Rep. 3:98–102. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
O'Brien CA, Jia D, Plotkin LI, Bellido T,
Powers CC, Stewart SA, Manolagas SC and Weinstein RS:
Glucocorticoids act directly on osteoblasts and osteocytes to
induce their apoptosis and reduce bone formation and strength.
Endocrinology. 145:1835–1841. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Paget S: Steroids cause osteoporosis. Ann
Rheum Dis. 61:1–3. 2002.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Harder AT and An YH: The mechanisms of the
inhibitory effects of nonsteroidal anti-inflammatory drugs on bone
healing: A concise review. J Clin Pharmacol. 43:807–815.
2003.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Pountos I, Georgouli T, Calori GM and
Giannoudis PV: Do nonsteroidal anti-inflammatory drugs affect bone
healing? A critical analysis. ScientificWorldJournal.
2012(606404)2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Chang JK, Li CJ, Wu SC, Yeh CH, Chen CH,
Fu YC, Wang GJ and Ho ML: Effects of anti-inflammatory drugs on
proliferation, cytotoxicity and osteogenesis in bone marrow
mesenchymal stem cells. Biochem Pharmacol. 74:1371–1382.
2007.PubMed/NCBI View Article : Google Scholar
|
|
11
|
García-Martínez O, De Luna-Bertos E,
Ramos-Torrecillas J, Manzano-Moreno FJ and Ruiz C: Repercussions of
NSAIDS drugs on bone tissue: The osteoblast. Life Sci. 123:72–77.
2015.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Díaz-Rodríguez L, García-Martínez O, De
Luna-Bertos E, Ramos-Torrecillas J and Ruiz C: Effect of ibuprofen
on proliferation, differentiation, antigenic expression, and
phagocytic capacity of osteoblasts. J Bone Miner Metab. 30:554–560.
2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
De Luna-Bertos E, Ramos-Torrecillas J,
García-Martínez O, Guildford A, Santin M and Ruiz C: Therapeutic
doses of nonsteroidal anti-inflammatory drugs inhibit osteosarcoma
MG-63 osteoblast-like cells maturation, viability, and
biomineralization potential. ScientificWorldJournal.
2013(809891)2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Costela-Ruiz VJ, Melguizo-Rodríguez L,
Illescas-Montes R, Ramos-Torrecillas J, Manzano-Moreno FJ, Ruiz C
and Bertos EL: Effects of therapeutic doses of celecoxib on several
physiological parameters of cultured human osteoblasts. Int J Med
Sci. 16:1466–1472. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wheatley BM, Nappo KE, Christensen DL,
Holman AM, Brooks DI and Potter BK: Effect of NSAIDs on bone
healing rates: A meta-analysis. J Am Acad Orthop Surg.
27:e330–e336. 2019.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Lisowska B, Kosson D and Domaracka K:
Positives and negatives of nonsteroidal anti-inflammatory drugs in
bone healing: The effects of these drugs on bone repair. Drug Des
Devel Ther. 12:1809–1814. 2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Geusens P, Emans PJ, de Jong JJ and van
den Bergh J: NSAIDs and fracture healing. Curr Opin Rheumatol.
25:524–531. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Beck A, Salem K, Krischak G, Kinzl L,
Bischoff M and Schmelz A: Nonsteroidal anti-inflammatory drugs
(NSAIDs) in the perioperative phase in traumatology and orthopedics
effects on bone healing. Oper Orthop Traumatol. 17:569–578.
2005.PubMed/NCBI View Article : Google Scholar : (In English,
German).
|
|
19
|
Gerstenfeld LC, Thiede M, Seibert K,
Mielke C, Phippard D, Svagr B, Cullinane D and Einhorn TA:
Differential inhibition of fracture healing by non-selective and
cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J
Orthop Res. 21:670–675. 2003.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Herbenick MA, Sprott D, Stills H and
Lawless M: Effects of a cyclooxygenase 2 inhibitor on fracture
healing in a rat model. Am J Orthop (Belle Mead NJ). 37:E133–E137.
2008.PubMed/NCBI
|
|
21
|
Manzano-Moreno FJ, Costela-Ruiz VJ,
Melguizo-Rodriguez L, Illescas-Montes R, García-Martínez O, Ruiz C
and Ramos-Torrecillas J: Inhibition of VEGF gene expression in
osteoblast cells by different NSAIDs. Arch Oral Biol. 92:75–78.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Hadjicharalambous C, Alexaki VI, Alpantaki
K and Chatzinikolaidou M: Effects of NSAIDs on the osteogenic
differentiation of human adipose tissue-derived stromal cells. J
Pharm Pharmacol. 68:1403–1408. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jain NX, Barr-Gillespie AE, Clark BD,
Kietrys DM, Wade CK, Litvin J, Popoff SN and Barbe MF: Bone loss
from high repetitive high force loading is prevented by ibuprofen
treatment. J Musculoskelet Neuronal Interact. 14:78–94.
2014.PubMed/NCBI
|
|
24
|
Darnis D, Veyrac G and Jolliet P: The
special case of diclofenac. Enliven: Pharmacovigil Drug Saf.
1(3)2014.
|
|
25
|
Schwarting T, Pretzsch S, Debus F,
Ruchholtz S and Lechler P: The effect of cyclooxygenase inhibition
on tendon-bone healing in an in vitro coculture model. Med
Inflammation. 2015(926369)2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Kidd LJ, Cowling NR, Wu AC, Kelly WL and
Forwood MR: Selective and non-selective cyclooxygenase inhibitors
delay stress fracture healing in the rat ulna. J Orthop Res.
31:235–242. 2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Vuolteenaho K, Moilanen T and Moilanen E:
Non-steroidal anti-inflammatory drugs, cyclooxygenase-2 and the
bone healing process. Basic Clin Pharmacol Toxicol. 102:10–14.
2008.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Marquez-Lara A, Hutchinson ID, Nunez F Jr,
Smith TL and Miller AN: Nonsteroidal anti-inflammatory drugs and
bone-healing: A systematic review of research quality. JBJS Rev.
4(01874474-201603000-00005)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Graham GG, Davies MJ, Day RO, Mohamudally
A and Scott KF: The modern pharmacology of paracetamol: Therapeutic
actions, mechanism of action, metabolism, toxicity and recent
pharmacological findings. Inflammopharmacology. 21:201–232.
2013.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kodama H, Amagai Y, Sudo H and Yamamoto S:
Establishment of a clonal osteogenic cell line from newborn mouse
calvaria. Jpn J Oral Biol. 23:899–901. 1981.
|
|
31
|
Golub E and Boesze-Battaglia KJ: The role
of alkaline phosphatase in mineralization. Curr Opin Orthopaedics.
18:444–448. 2007.
|
|
32
|
Hadjicharalambous C, Buyakov A, Buyakova
S, Kulkov S and Chatzinikolaidou M: Porous alumina, zirconia and
alumina/zirconia for bone repair: fabrication, mechanical and in
vitro biological response. Biomed Mater. 10(025012)2015.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Feng Y, Su L, Zhong X, Guohong W, Xiao H,
Li Y and Xiu L: Exendin-4 promotes proliferation and
differentiation of MC3T3-E1 osteoblasts by MAPKs activation. J Mol
Endocrinol. 56:189–199. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Hadjicharalambous C, Kozlova D, Sokolova
V, Epple M and Chatzinikolaidou M: Calcium phosphate nanoparticles
carrying BMP-7 plasmid DNA induce an osteogenic response in
MC3T3-E1 pre-osteoblasts. J Biomed Mater Res A. 103:3834–3842.
2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Evans CE and Butcher C: The influence on
human osteoblasts in vitro of non-steroidal anti-inflammatory drugs
which act on different cyclooxygenase enzymes. J Bone Joint Surg
Br. 86:444–449. 2004.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Arpornmaeklong P, Akarawatcharangura B and
Pripatnanont P: Factors influencing effects of specific COX-2
inhibitor NSAIDs on growth and differentiation of mouse osteoblasts
on titanium surfaces. Int J Oral Maxillofac Implants. 23:1071–1081.
2008.PubMed/NCBI
|
|
37
|
Gunaydin C and Bilge SS: Effects of
nonsteroidal anti-inflammatory drugs at the molecular level.
Eurasian J Med. 50:116–121. 2018.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Kotake S, Yago T, Kawamoto M and Nanke Y:
Effects of NSAIDs on differentiation and function of human and
murine osteoclasts-crucial ‘Human osteoclastology’. Pharmaceuticals
(Basel). 3:1394–1410. 2010.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Pountos I, Giannoudis PV, Jones E, English
A, Churchman S, Field S, Ponchel F, Bird H, Emery P and McGonagle
D: NSAIDS inhibit in vitro MSC chondrogenesis but not
osteogenesis: Implications for mechanism of bone formation
inhibition in man. J Cell Mol Med. 15:525–534. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Hinz B, Cheremina O and Brune K:
Acetaminophen (paracetamol) is a selective cyclooxygenase-2
inhibitor in man. FASEB J. 22:383–390. 2008.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Díaz-Rodríguez L, García-Martínez O,
Arroyo-Morales M, Rubio-Ruiz B and Ruiz C: Effect of acetaminophen
(paracetamol) on human osteosarcoma cell line MG63. Acta Pharmacol
Sin. 31:1495–1499. 2010.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Melguizo-Rodriguez L, Costela-Ruiz VJ,
Manzano-Moreno FJ, Illescas-Montes R, Ramos-Torrecillas J,
García-Martínez O and Ruiz C: Repercussion of nonsteroidal
anti-inflammatory drugs on the gene expression of human
osteoblasts. PeerJ. 6(e5415)2018.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Nakatsu Y, Nakagawa F, Higashi S, Ohsumi
T, Shiiba S, Watanabe S and Takeuchi H: Effect of acetaminophen on
osteoblastic differentiation and migration of MC3T3-E1 cells.
Pharmacol Rep. 70:29–36. 2018.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Sivagurunathan S, Muir MM, Brennan TC,
Seale JP and Mason RS: Influence of glucocorticoids on human
osteoclast generation and activity. J Bone Miner Res. 20:390–398.
2005.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Mitra R: Adverse effects of
corticosteroids on bone metabolism: A review. PM R. 3:466–471.
2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Hong D, Chen HX, Ge RS and Li JC: The
biological roles of extracellular and intracytoplasmic
glucocorticoids in skeletal cells. J Steroid Biochem Mol Biol.
111:164–170. 2008.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Nagano A, Arioka M, Takahashi-Yanaga F,
Matsuzaki E and Sasaguri T: Celecoxib inhibits osteoblast
maturation by suppressing the expression of Wnt target genes. J
Pharmacol Sci. 133:18–24. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Hachemi Y, Rapp AE, Picke AK, Weidinger G,
Ignatius A and Tuckermann J: Molecular mechanisms of
glucocorticoids on skeleton and bone regeneration after fracture. J
Mol Endocrinol. 61:R75–R90. 2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Asirvatham S, Dhokchawle BV and Tauro SJ:
Quantitative structure activity relationships studies of
non-steroidal anti-inflammatory drugs: A review. Arabian J Chem.
12:3948–3962. 2019.
|
|
50
|
Michaelidou AS and Hadjipavlou-Litina D:
Nonsteroidal anti-inflammatory drugs (NSAIDs): A comparative QSAR
study. Chem Rev. 105:3235–3271. 2005.PubMed/NCBI View Article : Google Scholar
|
